15^th Global Biomarkers and Clinical Research Summit

About Conference

Biomarkers in other words, biological markers deal with medical science being a source of identification and observation of varied underlying diseases. Observable signs are sometimes in contrast to medical symptoms, which are limited to those indications of health or illness perceived by patients themselves. They allow the assessment of those symptoms by a therapeutic interference thereby framing a pharmacological response.

We are delighted to welcome you to the prestigious 15th Global Biomarkers and Clinical Research Summit. Biomarkers 2020 brings together experts from all aspects to meet and discuss the future of Biomarkers &Clinical Research, Importance in today's world to thrive and survive with better health. The conference will be held on September 17 and 18 2020 at Vienna, Austria which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. We are optimistic that you will appreciate this upcoming Conference's Scientific Program

Vienna has been finalized as the venue for the summit and is full of tourist’s attraction places. We welcome participants from all over the globe to join us for the summit as well as to explore the beautiful city.

The attendees can build up the knowledge through exclusive sessions and panel discussions on latest innovations in Clinical Research & Vaccines and Drug Development

• Poster presentations by Young Researchers

• Keynote forums by Prominent Professors, Doctors

• Open Innovation Challenges

• Lectures from renowned speakers

• Novel techniques to benefit your research

• Global Networking sessions with 50+ Countries

Sessions/Tracks

Market Analysis

Industry Insights

The international market of Biomarkers was valued at around 40 billion USD in 2018 and is expected to increase by a CAGR of 13.7% by 2026. The major share of biomarkers is due to the advancements in biomarker based diagnostics.

The market of biomarkers is growing at an alarming rate due to the increase in the international diseases such as cancer, diabetes and Cardiovascular Diseases which are mainly caused due to the lifestyle changes like unhealthy diet, unhealthy lifestyle, lack of exercise and rest. The World health organization mentioned that these diseases contribute to around 50% of the total number of deaths annually.

Due to the advancements in technology, it is now possible to combine biomarkers with oral drugs to improve the accuracy of treatment. Biomarkers are also used to treat brain disorders and diseases by measuring the brain health over a period of time. Due to the recent advancements in biomarker treatments, the brain diseases can be treated with ease which results in cost cutting and early diagnosis of the patient.

The government is also proving a helping hand by providing initiatives to the patients and cutting the price of healthcare. It is also providing help by shifting their focus on early detection techniques and early cure of disease.

Disease Insights

The biomarkers market was led by the cancer section during 2018 followed by cardiovascular diseases and neurological diseases. This shows that there is an ever increasing demand for diagnostic requirements for cancer cure. The future market is expected to grow in the personalized medicine and strategic medicine field.

Past Conference Report